News

AS a marathon runner and someone who’d never smoked, Warren Gray wasn’t worried when he developed what he thought was an ...
Alecensa (alectinib) is now an option for patients with stage 1b to 3a ALK-positive NSCLC who have ... In another positive development for the lung cancer community, NICE has also given its ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...
A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new ...
ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...
Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...
A brief nurse-led intervention had a greater effect on dyspnea among patients who experience improvement in their psychological distress.
Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung ...
A recent study on the application of metagenomic next-generation sequencing (mNGS) found that mNGS can achieve early ...
Zai Lab Limited ( NASDAQ: ZLAB) said on Monday that it received U.S. FDA fast track designation for its antibody-drug ...
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...